학술논문
LBA-009 - KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer
Document Type
Abstract
Author
Source
In Annals of Oncology June 2017 28 Supplement 3:iii153-iii153
Subject
Language
ISSN
0923-7534